Skip to main content

Table 1 Patient demographics and clinical details

From: “Living a normal life”: a qualitative study of patients’ views of medication withdrawal in rheumatoid arthritis

Demographic / clinical data Value
Number of patients recruited 13
Female [%] 8 [53%]
Age: median [IQR, range] years 65 [61–73, 44–85]
Time since RA diagnosis: median [IQR] years 10 [3–13]
RhF and/or ACPA positive: n [%] 9 [69%]
Current use of methotrexate: n [%] 11 [85%]
Current use of hydroxychloroquine: n [%] 1 [8%]
Current use of sulfasalazine: n [%] 2 [15%]
Current use of biologics: n [%] 2 [15%]
DAS28: median [IQR] 1.56 [1.35–2.44]
  1. ACPA: anti-citrullinated peptide antibody: IQR: interquartile range, RhF: rheumatoid factor